Duffy Sean P. 的 Form 4/A 修正申報
修正Omada Health, Inc.(OMDA),2026/7/8 申報
- 申報編號
- 0001610717-26-000335
- 申報時間
- 2026/7/8 20:22 ET
- 交易日
- 2026/6/24-6/26
- 申報延遲
- 14 天
- 10b5-1 計畫
- 有勾選
- 原始申報日
- 2026/6/26
這份申報列了 8 筆非衍生性交易、4 筆衍生性交易。公開市場賣出合計 $34.2 萬。交易後 14 天申報。
這份修正申報取代了 0001610717-26-000299(2026/6/26 申報)。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Duffy Sean P.CIK 0002069522 | 董事、高階主管(執行長) |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/24 | Common Stock | M行使選擇權取得 | +2,800 | $5.82 | +$16,296 | 414,661 | 直接 | |
| 2026/6/24 | Common Stock | S賣出處分 | −2,800 | $19.01F3 | −$53,238.92 | 411,861 | 直接 | |
| 2026/6/25 | Common Stock | M行使選擇權取得 | +300 | $5.82 | +$1,746 | 412,161 | 直接 | |
| 2026/6/25 | Common Stock | S賣出處分 | −300 | $19.00F4 | −$5,700.99 | 411,861 | 直接 | |
| 2026/6/26 | Common Stock | M行使選擇權取得 | +9,844 | $5.82 | +$57,292.08 | 421,705 | 直接 | |
| 2026/6/26 | Common Stock | S賣出處分 | −9,844 | $19.61 | −$193,013.28 | 411,861 | 直接 | |
| 2026/6/26 | Common Stock | M行使選擇權取得 | +4,314 | $8.28 | +$35,719.92 | 416,175 | 直接 | |
| 2026/6/26 | Common Stock | S賣出處分 | −4,314 | $20.90 | −$90,162.6 | 411,861 | 直接 |
衍生性證券(表 II)
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/24 | Common Stock | M行使選擇權處分 | −2,800 | $0.00 | $0 | 178,515 | 直接 | |
| 2026/6/25 | Common Stock | M行使選擇權處分 | −300 | $0.00 | $0 | 178,215 | 直接 | |
| 2026/6/26 | Common Stock | M行使選擇權處分 | −9,844 | $0.00 | $0 | 168,371 | 直接 | |
| 2026/6/26 | Common Stock | M行使選擇權處分 | −4,314 | $0.00 | $0 | 129,019 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- F2
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F3
This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
- F6
100% of the shares subject to the option are fully vested and exercisable